BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30201085)

  • 1. Influence of apheresis collection device and container on the storage properties of platelets in 90% PAS-5/10% plasma.
    Wagner SJ; Hapip CA; Turgeon A; Abel L; Kaelber N
    Blood Transfus; 2019 May; 17(3):210-216. PubMed ID: 30201085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Storage of apheresis platelet concentrates after manual replacement of >95% of plasma with PAS 5.
    Morrison A; McMillan L; Radwanski K; Blatchford O; Min K; Petrik J
    Vox Sang; 2014 Oct; 107(3):247-53. PubMed ID: 24801569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution.
    Johnson L; Winter KM; Hartkopf-Theis T; Reid S; Kwok M; Marks DC
    Transfusion; 2012 Mar; 52(3):503-9. PubMed ID: 21880041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the effect of a platelet additive solution on apheresis platelet and fibrin network ultrastructure.
    Pretorius E; Crookes R; Oberholzer HM; van der Spuy WJ
    Transfus Apher Sci; 2010 Dec; 43(3):347-351. PubMed ID: 21036668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Washing platelets with new additive solutions: aspects on the in vitro quality after 48 hours of storage.
    Ringwald J; Althoff F; Zimmermann R; Strasser E; Weisbach V; Zingsem J; Eckstein R
    Transfusion; 2006 Feb; 46(2):236-43. PubMed ID: 16441601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the in vitro storage properties of Amicus apheresis platelets collected using single- and double-needle procedures from the same donors.
    Wagner SJ; Seetharaman S; Kurtz J
    Transfusion; 2012 Mar; 52(3):524-8. PubMed ID: 21880047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refrigeration of apheresis platelets in platelet additive solution (PAS-E) supports in vitro platelet quality to maximize the shelf-life.
    Johnson L; Vekariya S; Wood B; Tan S; Roan C; Marks DC
    Transfusion; 2021 Jul; 61 Suppl 1():S58-S67. PubMed ID: 34269458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of immediate or delayed addition of platelet additive solution on the in vitro quality of apheresis platelets.
    Ringwald J; Tully S; Geier C; Hauck B; Weiss D; Callaert M; Eckstein R
    Transfusion; 2012 Jun; 52(6):1237-44. PubMed ID: 22070790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of bicarbonate in platelet additive solution for apheresis platelet concentrates stored with low residual plasma.
    Radwanski K; Min K
    Transfusion; 2013 Mar; 53(3):591-9. PubMed ID: 22725609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of in vitro storage properties of apheresis platelets suspended in a bicarbonate-containing additive solution with low levels of plasma and stored with a 24-hour interruption of agitation.
    Skripchenko A; Turgeon A; Thompson-Montgomery D; Awatefe H; Wagner SJ
    Vox Sang; 2014 May; 106(4):337-43. PubMed ID: 24330192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early storage lesions in apheresis platelets are induced by the activation of the integrin αIIbβ₃ and focal adhesion signaling pathways.
    Thiele T; Iuga C; Janetzky S; Schwertz H; Gesell Salazar M; Fürll B; Völker U; Greinacher A; Steil L
    J Proteomics; 2012 Dec; 76 Spec No.():297-315. PubMed ID: 22634086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of plasma concentration to 10% improves a number of in vitro storage parameters of apheresis platelets suspended in a bicarbonate-containing additive solution and stored with a 24-hour interruption of agitation.
    Wagner SJ; Skripchenko A; Hapip CA; Kaelber N; Turgeon A
    Blood Transfus; 2018 May; 16(3):279-284. PubMed ID: 28287376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet storage in more than 90% additive solution containing glucose and bicarbonate has the potential to increase shelf life.
    Bashir S; Kemsley K; Min K; Swann ID; Cardigan R
    Transfusion; 2018 Dec; 58(12):2959-2968. PubMed ID: 30265746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the platelet activation status of single-donor platelets obtained with two different cell separator technologies.
    Millar D; Hayes C; Jones J; Klapper E; Kniep JN; Luu HS; Noland DK; Petitti L; Poisson JL; Spaepen E; Ye Z; Maurer-Spurej E
    Transfusion; 2020 Sep; 60(9):2067-2078. PubMed ID: 32729161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary characterization of the properties of cold-stored apheresis platelets suspended in PAS-III with and without an 8-hour room temperature hold.
    Wagner SJ; Getz TM; Thompson-Montgomery D; Turgeon A
    Transfusion; 2020 Nov; 60(11):2489-2493. PubMed ID: 32735027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven-day storage of apheresis platelets: report of an in vitro study.
    Dumont LJ; VandenBroeke T
    Transfusion; 2003 Feb; 43(2):143-50. PubMed ID: 12559008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of apheresis container size on the maintenance of platelet in vitro storage properties after a 30-h interruption of agitation.
    Wagner SJ; Skripchenko A; Seetharaman S; Myrup A; Kurtz J; Thomas-Montgomery D; Awatefe H; Moroff G
    Transfus Apher Sci; 2010 Aug; 43(1):9-15. PubMed ID: 20554476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between a new PVC platelet storage container (UPX80) and a polyolefin container.
    Kostelijk EH; Gouwerok CW; Veldman HA; de Korte D
    Transfus Med; 2000 Jun; 10(2):131-9. PubMed ID: 10849384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets stored in a new-generation container differences between plasma and platelet additive solution II.
    de Wildt-Eggen J; Schrijver JG; Smid WM; Joie M; Bollinne V; Bins M
    Vox Sang; 1998; 75(3):218-23. PubMed ID: 9852410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5.
    Radwanski K; Wagner SJ; Skripchenko A; Min K
    Transfusion; 2012 Jan; 52(1):188-94. PubMed ID: 21790624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.